about
Cloning and characterization of mCtBP2, a co-repressor that associates with basic Krüppel-like factor and other mammalian transcriptional regulatorsEctopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemiaTransforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer.AML1 interconnected pathways of leukemogenesisCooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemiaAltered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemiaSignificance of oncogenes and tumor suppressor genes in AML prognosis.Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.Myeloid neoplasm with t(3;8)(q26;q24): report of six cases and review of the literature.Identification of two critically deleted regions within chromosome segment 7q35-q36 in EVI1 deregulated myeloid leukemia cell linesThe oncoprotein EVI1 and the DNA methyltransferase Dnmt3 co-operate in binding and de novo methylation of target DNA.Differential display as an approach to study differentiation and differentiation therapy in AML.Genetic profile of acute myeloid leukemia.Transforming growth factor-beta signaling in normal and malignant hematopoiesis.Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features.Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AMLEVI1 promotes cell proliferation in HBx-induced hepatocarcinogenesis as a critical transcription factor regulating lncRNAs.The role of aberrant transcription factor in the progression of chronic myeloid leukemia.The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet.RUNX1 translocations and fusion genes in malignant hemopathies.Genetic events other than BCR-ABL1.PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias.3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review.Role of RUNX1 in hematological malignancies.EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells.An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies.Novel amplification unit at chromosome 3q25-q27 in human prostate cancer.Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas.Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia.Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms.MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.A discriminating screening is necessary to ascertain EVI1 expression by RT-PCR in malignant cells from the myeloid lineage without 3q26 rearrangement.Complex chromosomal rearrangements leading toMECOMoverexpression are recurrent in myeloid malignancies with various 3q abnormalities
P2860
Q24533307-ED8FD423-D433-4289-87DF-97E7D4EF2DEEQ24627258-0A7571B4-07ED-4DCE-8149-0E5A7FDF6567Q24793265-C51141F3-F005-4D9B-8BA5-DDE617FD3A53Q28184349-184309C0-D6B5-4F03-B9AA-05F0135408E1Q28214984-0D66571F-8096-4967-87FF-4672C1D6A2DFQ28216917-641E4F70-3C24-4F0F-A6CE-E31690E9F257Q30250315-15F1E8D5-6DBF-4D3E-B11F-C0E8F03AD9B6Q33270804-483D96C8-E716-473E-9CC0-000D981D669DQ33412515-DFC302EE-158F-4633-9EBB-12DCF19F1189Q33525049-8D1D15C1-77B5-4039-AE99-6A0431328AACQ33939478-F3CB7C35-9634-4A35-8A18-800E9EA9EC2CQ34116902-0B4DB6A2-7BDE-4FB6-A695-DFB0442E2681Q34680927-843CFFBF-948E-4147-8374-64A6E3BDF351Q35217394-4F896BE7-FEE4-4C70-9450-FFB8480BDAD5Q35746083-AEEA5E8F-3CDC-40BC-B1DF-CB4D781F5E5EQ37116614-101561DD-F82E-43A6-A4E4-49C8F2205935Q37225429-6DE985C4-CE2A-4204-8C3B-33F0B13C7312Q37259355-A28C0279-3A3F-46AD-8355-C1E7BA7DC51FQ37513316-6B3AA3AE-ED49-4A41-8BB2-F5F3176655FFQ37545067-AE178BB1-4606-405B-9E2B-7CB8793EB78DQ37822736-52C09DAC-D2EB-4EE8-9863-1FAE3608145EQ38177162-02FBB0B9-F2D5-4657-93DF-965214565640Q38438690-A241AE84-2B27-40EB-A7E6-C0952925BC47Q38515835-5969AF6F-141F-48F6-AB36-EBC3B5791255Q39127024-BD9C4973-B5F1-4E9A-AD14-A617DFE02247Q39543410-7C4672D6-A965-4988-AECC-9DC1BACDC50DQ40162781-5A1D7804-11F4-495F-A264-A6E3A1B1938BQ40842954-AB095253-1526-423E-AF47-E2451E0870A4Q42105764-8C7B1429-26A7-4D58-8EAF-5C77B88173FFQ42218756-0139E4FB-ECC4-4F38-9E64-D49BF7A58B12Q46958461-019C82C7-B238-4656-98FD-DFC614365F2FQ49054744-B61C613E-2787-4017-88EB-883C9DA6A258Q50776559-729C8675-230C-4D2F-8FB4-2776AC58B1A4Q53344487-3423ECCA-2FD0-499E-848D-813D13E679E4Q54608168-95CC294E-D415-4089-AF5F-563807E91CFDQ54783427-478D4602-95B8-4991-81B5-BF3F953AAA35Q57903906-DF1DBAED-CAFF-48EF-A2B8-1C30E6CE6526
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The EVI1 gene in myeloid leukemia.
@en
type
label
The EVI1 gene in myeloid leukemia.
@en
prefLabel
The EVI1 gene in myeloid leukemia.
@en
P356
P1433
P1476
The EVI1 gene in myeloid leukemia.
@en
P2093
Nucifora G
P2888
P304
P356
10.1038/SJ.LEU.2400880
P577
1997-12-01T00:00:00Z
P5875
P6179
1048911662